AstraZeneca PLC (NYSE:AZN) average daily volatility for this week is 1.49% which is less than the 1.74% recorded over the past month. Its shares dropped by -4.04% or -$1.69 from its last recorded high of $41.78 which it attained on November 13 to close at $40.09 per share. Over the past 52 weeks, the shares of AstraZeneca PLC has been trading as low as $31.99 before witnessing a massive surge by 25.32% or $8.1. This price movement has led to the AZN stock receiving more attention and has become one to watch out for. It dipped by -0.27% on Monday and this got the market worried. The stock’s beta now stands at 0.5 and when compared to its 200-day moving average and its 50-day moving average, AZN price stands 8.74% above and 2.73% above respectively.
AstraZeneca PLC (AZN) sank -1.43% this week, a trend that has led to both investors and traders taking note of the stock. Over the past one year, the equity price has embarked on a rally that has seen it rise 18.47% and is now up by 15.53% since start of this year. A look at its monthly performance shows that the stock has recorded a 6.11% gain over the past 30 days. Its equity price climbed by 3.86% over the past three months which led to its overall six-month increase to stand at 10.2%.
A look at AZN technical analysis shows that its 14-day Relative Strength Index (RSI) is in a neutral zone after reaching 51.31 point. Its trading volume has lost -536039 shares compared to readings over the past three months as it recently exchanged 3673961 shares. This means there is reduced activity from short-term traders as per session, its average trading volume is 4210000 shares, and this is 0.87 times the normal volume.
Analysts have predicted a price target for The Procter & Gamble Company (PG) for 1 year and it stands at an average $89.29/share. This means that it would likely increase by -2.88% from its current position. Some brokerage firms have a lower target for the stock than the average, with one of them setting a price target as low as $78. On the other hand, one analyst is super bullish about the price, setting a target as high as $100.
Analysts view The Procter & Gamble Company (NYSE:PG) as a Hold, with 2.6 consensus rating. Reuters surveyed 24 analysts that follow PG and found that 16 of those analysts rated the stock as a Hold. The remaining 8 were divided, with 7 analyst rating it as a Buy or a Strong Buy while 1 analysts advised investors to desist from buying The Procter & Gamble Company (PG) shares or sell it if they already own it.